RSS-Feed abonnieren
DOI: 10.1055/s-0038-1661691
Three Abnormal Fibrinogen Variants with the Same Amino Acid Substitution (γ 275 Arg → His): Fibrinogens Bergamo II, Essen and Perugia
Publikationsverlauf
Received 10. Juli 1986
Accepted after revision 26. September 1986
Publikationsdatum:
18. Juli 2018 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00035024/198603/lookinside/thumbnails/10-1055-s-0038-1661691-1.jpg)
Summary
We report on three unrelated individuals with the same uncommon type of dysfibrinogenemia, originating from Bergamo, Essen and Perugia. None of them showed bleeding symptoms while the Bergamo patient and members of her family presented with a thrombotic tendency. The presence of a defective fibrinogen was suggested by prolonged thrombin and rep-tilase times. Furthermore, fibrinogen concentrations of less than 0.28 g/L were determined by the functional assay whereas values of 1.5-2.4 g/L were measured by heat precipitation or electroimmunoassay. Fibrinogen was isolated by affinity chromatography on insoluble fibrin monomer. The rate of fibrinopeptide release by thrombin was normal while the fibrin polymerization reaction was strongly delayed. An abnormal peptide (γ265-310) was isolated by high-performance liquid chromatography after cyanogen bromide cleavage of the purified γ-chain of fibrinogen Bergamo II and Essen. The same peptide was also isolated following cyanogen bromide treatment of the intact fibrinogen Perugia. Sequence analyses of these peptides demonstrated the same amino acid exchange in all three fibrinogens: γ275 arginine → histidine. The described fibrinogen variants appear to possess a molecular defect which has thus far only been observed in fibrinogen Haifa.
-
References
- 1 Rupp C, Beck EA. Congenital dysfibrinogenemia. In: Variants of human fibrinogen. Beck EA, Furlan M. (eds) Huber; Bern: 1984: 65-130
- 2 Henschen A, Kehl M, Southan C. Genetically abnormal fibrinogens -strategies for structure elucidation, including fibrinopeptide analysis.. In: Variants of human fibrinogen Beck EA, Furlan M. (eds) Huber; Bern: 1984: 273-320
- 3 Kudryk BJ, Collen D, Woods KR, Blombäck B. Evidence for localization of polymerization sites in fibrinogen. J Biol Chem 1974; 249: 3322-3325
- 4 Olexa SA, Budzynski AZ. Localization of a fibrin polymerization site. J Biol Chem 1981; 256: 3544-3549
- 5 Furlan M, Rupp C, Beck EA, Svendsen L. Effect of calcium and synthetic peptides on fibrin polymerization. Thromb Haemostas 1982; 47: 118-121
- 6 Laurell CB. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 1966; 15: 45-52
- 7 Schulz FH. Eine einfache Bewertungsmethode von Leberparenchym-schäden (volumetrische Fibrinbestimmung). Acta Hepatolog 1955; 3: 306-310
- 8 Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957; 17: 237-246
- 9 Kehl M, Lottspeich F, Henschen A. Analysis of human fibrinopep-tides by high-performance liquid chromatography. Hoppe-Seyler’s Z Physiol Chem 1981 362: 1661-1664
- 10 Henschen A, Edman P. Large scale preparation of S-carboxymethy-lated chains of human fibrin and fibrinogen and the occurrence of γ-chain variants. Biochim Biophys Acta 1972; 263: 351-367
- 11 Kehl M, Lottspeich F, Henschen A. High-performance liquid chromatography of proteins as applied to fibrinogen chains. Hoppe-Seyler’s Z Physiol Chem 1982; 363: 1501-1505
- 12 Edman P, Henschen A. Sequence determination. In: Protein Sequence Determination. 2nd Edition Needleman SB. (ed) Springer; Berlin: 1975: 232-279
- 13 Brandt WF, Edman P, Henschen A, von Holt C. Abnormal behaviour of proline in the isothiocyanate degradation. Hoppe-Seyler’s Z Physiol Chem 1976; 357: 1505-1508
- 14 Lottspeich F. Identification of the phenylthiohydantoin derivatives of amino acids by high pressure liquid chromatography using a ternary isocratic solvent system. Hoppe-Seyler’s Z Physiol Chem 1980; 361: 1829-1834
- 15 Kehl M, Lottspeich F, Henschen A. High performance liquid chromatography as applied to the studies of the fibrinogen structure. In: Practical Aspects of Modern HPLC Molnar I. (ed) de Gruyter; Berlin: 1982: 137-159
- 16 Nieuwenhuizen W, Voskuilen M, Vermond A, Haverkate F, Hermans J. A fibrinogen fragment D (D intermediate) with calcium binding but without anticlotting properties. Biochim Biophys Acta 1982; 707: 190-192
- 17 Kudryk B, Reuterby J, Blomäack B. Adsorption of plasmic fragment D to thrombin modified fibrinogen-Sepharose. Thromb Res 1973; 2: 297-304
- 18 Southan C, Thompson E, Panico M, Etienne T, Morris HR, Lane DA. Characterization of peptides cleaved by plasmin from the C-terminal polymerization domain of human fibrinogen. J Biol Chem 1985; 260: 13095-13101
- 19 Varadi A, Scheraga HA. Localization of segments essential for polymerization and for calcium binding in the γ-chain of human fibrinogen. Biochemistry 1986; 25: 519-528
- 20 Reber P, Furlan M, Rupp C, Kehl M, Henschen A, Mannucci PM, Beck EA. Characterization of Milano I: Amino acid exchange γ330Asp → Val impairs fibrin polymerization. Blood 1986; 67: 1751-1756
- 21 Lottspeich F, Henschen A. Amino acid sequence of human fibrin. Preliminary note on the completion of the γ-chain sequence. Hoppe-Seyler’s Z Physiol Chem 1977; 358: 935-938
- 22 Crabtree GR, Kant JA. Organization of rat γ-fibrinogen gene: Alternative mRNA splice patterns produce the γA and γB (γ′) chains of fibrinogen. Cell 1982; 31: 159-166
- 23 Strong DD, Moore M, Cottrell BA, Bohonus VL, Pontes M, Evans B, Riley M, Doolittle RF. Lamprey fibrinogen γ chain: cloning, cDNA sequencing, and general characterization. Biochemistry 1985; 24: 92-101
- 24 Chung DW, Chan WY, Davie EW. Characterization of a complementary deoxyribonucleic acid coding for the γ-chain of human fibrinogen. Biochemistry 1983; 22: 3250-3256
- 25 Kehl M, Henschen A, Soria J, Soria C, Nieuwenhuizen W, Tabori S, Rimon A. (In preparation)
- 26 Brook JG, Tabori S, Tatarsky I, Hashmonai M, Schramek A. Fibrinogen “Haifa” - a new fibrinogen variant. A case report. Haemostasis 1983; 13: 277-281